NCT05652595View on ClinicalTrials.gov

Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141

PHASE1UnknownINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

June 3, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

September 30, 2024

Conditions
PharmacodynamicsPharmacokineticsBioequivalence
Interventions
DRUG

GP40141

Once, at a dose of 3 mcg/kg, Subcutaneously in the shoulder area

DRUG

Nplate

Once, at a dose of 3 mcg/kg, Subcutaneously in the shoulder area

Trial Locations (1)

150007

RECRUITING

"Yaroslavl Region Clinical Hospital No. 3, ,, Mayakovskogo st., 61", Yaroslavl

Sponsors

Lead Sponsor

Geropharm
All Listed Sponsors
lead

Geropharm

INDUSTRY